Welcome!

News Feed Item

Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)

DUBLIN, Mar. 20, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug

) has announced the addition of the

"Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)"

conference to their offering.



(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The Injectable Drug Delivery Conference will be held on the 26th & 27th March 2014 at Le Meridien Hotel, Piccadilly, London



KEY TOPICS TO INCLUDE:


- Market trends


- Human factors and useability


- Fluid dynamics - modelling the realities of injection performance


- Delivery of high viscosity drugs


- Case study presentation on devices in development


- Latest self injection trends


- Development of a parenteral device


- Delivery of high volumes


- Compliance modelling and parenteral drug delivery


- The insulet drug delivery system



DATES:



26 & 27 March 2014



TIMES:



Day One: 26 March 2013


Start times: 9.30 Finish 17.45



Drinks Reception Followed by Dinner 19.30



Day Two: 27 March 2013


Start times: 9.00 Finish 16.15



VENUE FOR CONFERENCE AND DINNER:



Le Meridien Hotel, Piccadilly, London



NOTE: Please note that there is a Pre-conference seminar on 25th March on 'Prefilled Syringes - Advances in Manufacture' and also a Post Conference Workshop on 28th March on 'Human Factors and Usability Engineering in the development of drug delivery products'.



Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged



Key Topics Covered:



INJECTABLE DRUG DELIVERY DAY ONE - 26 March 2013



09.30 - Chairman's Welcome and Introduction


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.40 - Key Note Address: Market Trends



- High concentration formulations



- Larger doses, less frequent injections


Mathias Romacker, Drug Delivery Devices and Business Development, Amgen, USA



10.20 - Human Factors and Useability



- Ethonographic research on atuoinjector use for chronic conditions



- Relationship between a disease and its therapy - emotional and functional levels



- How this affects device selection


Mathew Young, CEO, Oval Medical Technologies Ltd, UK



11.00 - Discussion followed by Coffee



11.30 - Fluid Dynamics - Modelling the Realities of Injection Performance



- Mathematical modelling enables the opportunities and challenges of a range of device types to be explored early



- The implications of such characteristics as viscosity, dose volume and injection frequency are inseparable from the choice of delivery device



- Unfortunately, early consideration of the delivery device does not always take place. Opportunities can thus be lost and problems created which are costly and difficult to solve later



- Mathematical modelling techniques, applied properly, improve understanding of the issues concerned and enable better and earlier decisions to be taken



- Better informed decisions and better appreciations of the design options in turn support device designs which are better for the end user



- Early understanding of device issues supports and enables robust designs and capable manufacture



- Early understanding can shorten development timescales, in turn making earlier approval and earlier revenues possible


Andy Fry, Founder, Team Consulting, UK



12.10 - Delivery of High Viscosity Drugs



- Device formats



- Overcoming the challenges


Speaker, (invited)



12.50 - Discussion followed by Lunch



14.10 - Mixing Technologies for Reconstitution Devices



- Market Needs - Industry drivers and demands for these types of devices



- Latest mixing technologies



- Comparison of Lyophilised and Spray drying technologies



- Technical challenges with these types of devices


Tom Bailey, Managing Director, 3PInnovation, UK



14.50 - Device Case Study


Ian Anderson, Innovation Director, Bespak UK (invited)



15.30 - Discussion followed by Tea



16.10 - Latest Self Injection Trends



- General market trends



- Trends for biologics



- Trends for generics



- Pre-configured devices



- Future outlook


Mats Persson, Managing Director, SHL Group, Sweden



16.50 - Innovation in Primary Container Materials



- Trends for user requirements intended for self injection



- Material technology options and selection criteria



- Integration of Quality by Design for components



- Platform approach for lifecycle management


Tibor Hlobik, West Pharmaceutical Services



17.30 - Discussion



17.45 - End of Day One



19.30 - Drinks Reception Followed by Dinner at Le Meridien Hotel, London



INJECTABLE DRUG DELIVERY DAY TWO - 27 March 2013



09.00 - Review of Day One


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.10 - What Does Pharma Want From its Drug Delivery Suppliers


Nick Bowman, Senior Director, Head of Devices COE, Pfizer, UK



09.50 - Pump Technology Case Study


Jonathan Rigby, President & CEO, SteadyMed Therapeutics Inc, USA, (invited)



10.30 - Discussion followed by Coffee



11.10 - Compliance Monitoring and Parenteral Drug Delivery



- Why is the industry suddenly talking about compliance and adherence monitoring (clinical trials and commercial applications)



- Advances in wireless communications enabling intelligent compliance monitoring



- The widespread availability of smart devices and their use in compliance monitoring, adherence and patient education



- Use of smartphone / smart devices apps for providing real-time information display and the potential for two way communications with the patient



- Regulatory issues associated with connected health systems and smartphone apps



- Using the cloud to store and disseminate data securely


Mark Tuckwell, Senior Consultant, Connected Health Systems,


Sagentia, UK



11.50 - Wireless Communication and Electronics for Compliance Monitoring



- Patient therapy compliance continues to be one of the biggest challenges in health systems



- 50% of all patients do not complete required treatment



- Reasons for the high rate of non-compliance



- Opportunities for medical manufacturers to offer innovative solutions



- Electronic compliance aids open interesting possibilities to remind, monitor and track patients' behavior, as well as to share vital therapy information with healthcare providers



- Key technologies that facilitate compliance, ranging from low-cost disposable electronics for dose counts and logs to a complete cloud-based system for monitoring compliance


Lior Shtram, Director, Design & Engineering, Flextronics Medical, Israel



12.30 - Discussion followed by Lunch



14.00 - Update on Regulations and Standards


Lee Leichter, President P/L Medical, USA



14.40 - The Insulet Drug Delivery System



Consists of two components


- Drug Delivery Pod


- Drug Delivery Manager



A Programmable, body worn, disposable, subcutaneous infusion pump



- Delivers up to 2ml of drug product over a three day period


- Delivery rate from 0.5 to 300 µl/hr


- Automated catheter insertion


- Waterproof (IPX8 25 feet for up to 60 minutes)



Provides the HCP and user maximum control, versatility, comfort and safety, while overcoming the numerous drawbacks of conventional infusion pump systems


Kevin Schmid, Vice President, Business Development & Advanced Technology Insulet Corporation, USA



15.20 - The Rise of the Bolus Injector



The changing needs of patients and new drugs are driving the growth of a new class of injection device: the large volume' or bolus' injector. This presentation will report the findings of a new research project run in collaboration with the Judge Business School, covering:



- The changing needs of patients and new drugs



- Could autoinjectors and infusion pumps meet the needs?



- Bolus injectors: a new class of injection device



- Example devices



- What to expect from the draft standard ISO 11608-6' on bolus injectors.


Tom Oakley, Director of Drug Delivery Device Development, Springboard, UK



16.00 - Discussion and Chairman's Closing Remarks



16.15 - End of Conference and Tea




For more information visit

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug



Media Contact:

Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
As people view cloud as a preferred option to build IT systems, the size of the cloud-based system is getting bigger and more complex. As the system gets bigger, more people need to collaborate from design to management. As more people collaborate to create a bigger system, the need for a systematic approach to automate the process is required. Just as in software, cloud now needs DevOps. In this session, the audience can see how people can solve this issue with a visual model. Visual models ha...
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, will discuss how they b...
SYS-CON Events announced today that Avere Systems, a leading provider of hybrid cloud enablement solutions, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Avere Systems was created by file systems experts determined to reinvent storage by changing the way enterprises thought about and bought storage resources. With decades of experience behind the company’s founders, Avere got its ...
Containers are rapidly finding their way into enterprise data centers, but change is difficult. How do enterprises transform their architecture with technologies like containers without losing the reliable components of their current solutions? In his session at @DevOpsSummit at 21st Cloud Expo, Tony Campbell, Director, Educational Services at CoreOS, will explore the challenges organizations are facing today as they move to containers and go over how Kubernetes applications can deploy with lega...
SYS-CON Events announced today that Avere Systems, a leading provider of enterprise storage for the hybrid cloud, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Avere delivers a more modern architectural approach to storage that doesn't require the overprovisioning of storage capacity to achieve performance, overspending on expensive storage media for inactive data or the overbui...
In the fast-paced advances and popularity in cloud technology, one of the most critical factors revolves around concerns for security of your critical data. How to assure both your company and your customers they can confidently trust and utilize your cloud environment is most often top on the list. There is a method to evaluating and providing security that exceeds conventional modes of protecting data both within the cloud as well externally on mobile and other devices. With the public failure...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
Today most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes significant work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reducti...
Microsoft Azure Container Services can be used for container deployment in a variety of ways including support for Orchestrators like Kubernetes, Docker Swarm and Mesos. However, the abstraction for app development that support application self-healing, scaling and so on may not be at the right level. Helm and Draft makes this a lot easier. In this primarily demo-driven session at @DevOpsSummit at 21st Cloud Expo, Raghavan "Rags" Srinivas, a Cloud Solutions Architect/Evangelist at Microsoft, wi...
Coca-Cola’s Google powered digital signage system lays the groundwork for a more valuable connection between Coke and its customers. Digital signs pair software with high-resolution displays so that a message can be changed instantly based on what the operator wants to communicate or sell. In their Day 3 Keynote at 21st Cloud Expo, Greg Chambers, Global Group Director, Digital Innovation, Coca-Cola, and Vidya Nagarajan, a Senior Product Manager at Google, will discuss how from store operations...
SYS-CON Events announced today that IBM has been named “Diamond Sponsor” of SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California.